Abstract
Although statins significantly decrease the incidence of cardiovascular disease (CVD), residual CVD risk remains high. This may partly be due to uncorrected atherogenic dyslipidaemia. The driving force behind atherogenic dyslipidaemia...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have